Plasma tetranectin as a potential clinical biomarker for epilepsy and correlation with clinical and social characteristics

Conclusion The plasma tetranectin level in PWE significantly decreased as the disease progressed irrespective of the stage of epilepsy. Thus, tetranectin could be considered as a potential progressive biomarker for epilepsy. The study outcome suggests further investigation for the possible link of tetranectin levels with clinical and social parameters.
Source: International Journal of Epilepsy - Category: Neurology Source Type: research